Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy

被引:21
作者
Lin, Joseph [1 ,2 ]
Lin, Kuo-Juei [3 ]
Wang, Yu-Fen [4 ]
Huang, Ling-Hui [1 ]
Chen, Sam Li-Sheng [5 ]
Chen, Dar-Ren [1 ,4 ,6 ]
机构
[1] Changhua Christian Hosp, Comprehens Breast Canc Ctr, 135 Nanhsiao St, Changhua 500209, Taiwan
[2] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 407302, Taiwan
[3] I Shou Univ, E Da Hosp, Dept Surg, Kaohsiung 824410, Taiwan
[4] Changhua Christian Hosp, Canc Res Ctr, Dept Res, Changhua 500209, Taiwan
[5] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei 110301, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung 402367, Taiwan
关键词
Neoadjuvant; Breast-conserving surgery; Surgical margin; Recurrence; PREOPERATIVE CHEMOTHERAPY; ADJUVANT BREAST; CARCINOMA LARGER; TUMOR RECURRENCE; CANCER PATIENTS; CONSERVATION; CONSENSUS; EXCISION; THERAPY; WOMEN;
D O I
10.1186/s12885-020-06955-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe aim of the current study was to report a single-institution experience using breast-conserving surgery after neoadjuvant chemotherapy (NACT), focusing on the association between microscopic resection margin status and locoregional recurrence (LRR).MethodsOur institutional prospectively maintained database was reviewed to identify patients who were treated with NACT between January 2008 and April 2018.ResultsAmong the main partial mastectomy specimens available for analysis (n=161), 28 had margins <1mm, 21 had margin width of 1-2mm and the remaining 112 had margins >2mm. LRR occurred in 16 patients (9.9%) and distant metastases were detected in 27 (16.8%) patients. There was no significant difference in the LRR between the >2mm margin group with a 60-month cumulative survival of 85.2% compared with 76.2% for the <= 2mm group (P= 0.335) in the Kaplan-Meier analysis. When we stratified patients by margin widths of >= 1mm or< 1mm, there was no LRR-free survival benefit observed for the <greater than or equal to>1mm pathologic excision margin group in the univariate analysis (hazard ratio=0.443; 95% confidence interval=0.142-1.383; P= 0.161) with a 60-month cumulative LRR-free survival of 84.9% compared with 69.5% for the <1mm margin cohort (P= 0.150).ConclusionsIn the absence of multiple scattered microscopic tumour foci, a negative margin of no ink on tumour maybe sufficient for stage I-III invasive breast cancer treated with NACT and breast-conserving surgery.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] MRI predictors of tumor-positive margins after breast-conserving surgery
    Bahl, Manisha
    Baker, Jay A.
    Kinsey, Emily N.
    Ghate, Sujata, V
    CLINICAL IMAGING, 2019, 57 : 45 - 49
  • [32] Neoadjuvant Chemotherapy does not Increase Complications in Oncoplastic Breast-Conserving Surgery
    Adamson, Karri
    Chavez-MacGregor, Mariana
    Caudle, Abigail
    Smith, Benjamin
    Baumann, Donald
    Liu, Jun
    Schaverien, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2730 - 2737
  • [33] A nationwide pathology study on surgical margins and excision volumes after breast-conserving surgery: There is still much to be gained
    Haloua, M. H.
    Volders, J. H.
    Krekel, N. M. A.
    Barbe, E.
    Sietses, C.
    Jozwiak, K.
    Meijer, S.
    van den Tol, M. P.
    BREAST, 2016, 25 : 14 - 21
  • [34] Breast cancer and neoadjuvant chemotherapy: indications for and limits of breast-conserving surgery
    Caldana, Marina
    Pellini, Francesca
    Lombardi, Davide
    Mirandola, Sara
    Invento, Alessandra
    Pollini, Giovanni Paolo
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (05) : 392 - 397
  • [35] Risk Factors for Locoregional Disease Recurrence After Breast-Conserving Therapy in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy: An International Collaboration and Individual Patient Meta-Analysis
    Valachis, Antonios
    Mamounas, Eleftherios P.
    Mittendorf, Elizabeth A.
    Hayashi, Naoki
    Ishitobi, Makoto
    Natoli, Clara
    Fitzal, Florian
    Rubio, Isabel T.
    Tiezzi, Daniel G.
    Shin, Hee-Chul
    Anderson, Stewart J.
    Hunt, Kelly K.
    Matsuda, Naoko
    Ohsumi, Shozo
    Totomi, Athina
    Nilsson, Cecilia
    CANCER, 2018, 124 (14) : 2923 - 2930
  • [36] Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer
    Shunrong Li
    Jieqiong Liu
    Yaping Yang
    Yunjie Zeng
    Heran Deng
    Haixia Jia
    Qian Li
    Huiyi Feng
    Yangyang Li
    Erwei Song
    Qiang Liu
    Fengxi Su
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 599 - 605
  • [37] Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Mamtani, Anita
    Sevilimedu, Varadan
    Le, Tiana
    Morrow, Monica
    Barrio, Andrea, V
    CANCER, 2022, 128 (03) : 471 - 478
  • [38] Surgical margin and breast recurrence after breast-conserving therapy
    Horiguchi, J
    Iino, Y
    Takei, H
    Maemura, M
    Yokoe, T
    Niibe, H
    Yamakawa, M
    Nakajima, T
    Oyama, T
    Morishita, Y
    ONCOLOGY REPORTS, 1999, 6 (01) : 135 - 138
  • [39] Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy
    Mrdutt, Mary
    Heerdt, Alexandra
    Sevilimedu, Varadan
    Mamtani, Anita
    Barrio, Andrea
    Morrow, Monica
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 484 - 492
  • [40] Case Report: A 3D-Printed Surgical Guide for Breast-Conserving Surgery After Neoadjuvant Chemotherapy
    Wu, Zhen-Yu
    Kim, Guk Bae
    Lee, Sangwook
    Choi, Seung Hyun
    Kim, Namkug
    Ko, BeomSeok
    FRONTIERS IN ONCOLOGY, 2021, 11